World News

Eli Lilly looks beyond GLP-1s with a $3 billion cancer buy

https://www.profitableratecpm.com/f4ffsdxe?key=39b1ebce72f3758345b2155c98e6709c

Eli Lilly announced it will acquire Kelonia Therapeutics for $3.25 billion upfront to expand its oncology and genetic medicines pipeline

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button